News

You can filter the posts based on tags:

New SYNERGIE magazine about „Exposome“ published

The first issue of SYNERGIE this year focuses on all external influences on the body. The DZL article deals with whether diseases can be diagnosed using exhaled air.

2024-05-31

Focus on new therapies for pulmonary hypertension

The German Research Foundation (DFG) has approved the third funding period for the Giessen Collaborative Research Centre 1213 on cardiopulmonary research - the researchers led by ILH and DZL scientist Prof. Dr Norbert Weißmann can thus build on numerous successes.

2024-05-29

Werner Seeger receives prestigious Lifetime Achievement Award at ATS congress

Prof Mareike Lehmann and Prof Werner Seeger were honoured at the ATS Congress in San Diego.

2024-05-27

Innate mechanism protects bacteria from last-resort antibiotic

A project at the ILH/DZL site UGMLC (Giessen, Marburg, Bad Nauheim) shows that bacteria protect themselves against a reserve antibiotic by releasing more vesicles.

2024-05-03

How obesity and pulmonary fibrosis are linked

The German Research Foundation (DFG) is funding a project by ILH scientists on the molecular link between obesity, ageing processes and chronic lung diseases.

2024-04-05

Rapid action against climate change protects against immune-mediated diseases

An international team of researchers, including ILH/DZL scientists Prof Harald Renz and Prof Chrysanthi Skevaki, is investigating how climate change, environmental pollution, and the decline in biodiversity affect our health.

2024-02-08

One million euros for cutting-edge medical research

The Von Behring-Röntgen Foundation is addressing life-threatening heart and lung diseases, antibiotic resistance, Parkinson's, and coronaviruses through its current research projects. A total of 1 million euros is supporting six innovative initiatives at Philipps University Marburg and Justus Liebig University Giessen, benefiting scientists from ILH and DZL among others, as announced during a ceremony at the foundation's headquarters.

2024-01-12

How the body repairs lung tissue after viral pneumonia

An international research team, led by lung researchers from Giessen, has discovered a new repair mechanism with therapeutic potential. The work has now been published in "Nature Communications."

« Previous 1 … 4 5 6 7 8 … 10 Next »

2024-04-05

Rapid action against climate change protects against immune-mediated diseases

2024-02-08

One million euros for cutting-edge medical research

2024-01-12

How the body repairs lung tissue after viral pneumonia

An international research team, led by lung researchers from Giessen, has discovered a new repair mechanism with therapeutic potential. The work has now been published in "Nature Communications."

2023-12-04

Young talents honored at the DPLD Young Investigator Meeting

On November 16th and 17th, 2023, the DPLD Young Investigator Meeting took place at the DZL site in Heidelberg. The latest scientific findings in the field of Interstitial Lung Diseases were exchanged, and young investigators were honored.

2023-11-27

DZL Academy Symposium - Young Scientists Gather in Berlin

"When regeneration goes berserk: challenges and strategies in lung remodeling" was the theme of the DZL Academy Symposium 2023, which brought together 80 young scientists from November 22nd to 24th in Berlin.

2023-11-14

New insights into potential therapeutic approaches for COPD

Chronic obstructive pulmonary disease (COPD) is considered an incurable condition worldwide and one of the leading causes of death. Researchers from the ILH have now presented groundbreaking findings that offer a promising approach for the therapy of COPD.

2023-11-03

Autoantibodies discovered as potential biomarkers in idiopathic pulmonary fibrosis

Scientists at the DZL/ILH sites in Munich and Hanover have discovered that newly discovered autoantibodies help to better assess the course of idiopathic pulmonary fibrosis.

2023-10-10

Macrophages as a therapeutic key for lung cancer

Lung cancer is considered the most frequently lethal tumor disease. ILH scientists have shown that the reprogramming of a specific group of white blood cells, known as tumor-associated macrophages, could be a promising approach for cancer therapy.

2023-10-05

Pulmonary hypertension: Molecular investigation of the remodelling processes in the heart

ILH scientist Prof. Dr. Soni Savai Pullamsetti and her team have discovered signalling pathways involved in developing right heart failure in patients with pulmonary hypertension. The findings provide new biomarkers for diagnosis and targets for future therapies.

« Previous 1 … 4 5 6 7 8 9 Next »

Archives